Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)
Completed
Conditions studied: Early Pancreatic Neoplasia, Familial Pancreatic Neoplasia
In brief
CAPS4 is a study at Johns Hopkins Hospital to study the diagnosis and long-term outcomes of screening patients with an increased inherited risk for pancreatic cancer.
Key facts
- Study ID
- NCT00714701
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- People needed
- 631
- Starts
- 2008-06-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2018-09-07
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- High Risk Group 1 (familial Peutz-Jeghers syndrome):
- At least 30 years old and <100 years old, and
- at least 2 of 3 criteria diagnostic of Peutz-Jeghers syndrome (characteristic intestinal hamartomatous polyps, mucocutaneous melanin deposition, or family history of Peutz-Jeghers syndrome)
- known STK-11 gene mutation carrier
- High Risk Group 2 (familial pancreatic cancer relatives):
- > 50 years old or 10 years younger than the age of youngest relative with pancreatic cancer, and < 80 years old
- come from a family with 2 or more members with a history of pancreatic cancer (2 of which have a first-degree relationship consistent with familial pancreatic cancer), and
- have a first-degree relationship with at least one of the relatives with pancreatic cancer.
- If there are 2 or more affected blood relatives, at least 1 must be a first-degree relative of the individual being screened
- High Risk Group 3 (germline mutation carriers):
- > 40 years old or 10 years younger than the age of the youngest relative with pancreatic cancer, and< 80 years old
- patient is carrier of a known BRCA1, BRCA2, PALB2, or FAMMM (p16/CDKN2A) mutation, and there is > 1 pancreatic cancer in the family, one of whom is a first- or second-degree relative of the subject to be screened.
- Hereditary pancreatitis syndrome
- High Risk Group 4 (young-onset pancreatic cancer relative):
- > 50 years old or 10 years younger than the age of youngest relative with pancreatic cancer, and < 80 years old
- have a first-degree relationship with at least one relative with young-onset pancreatic cancer ( age of onset < 50 years)
- High risk group 5 (both parents affected)
- > 50 years old or 10 years younger than the age of the youngest relative with pancreatic cancer, and< 80 years old
- two parents affected by pancreatic cancer
- Control 1 (Negative Controls):
- are undergoing EUS and/or ERCP for non-pancreatic indications as part of their standard medical care, and
- have no clinical or radiologic suspicion of pancreatic disease (chronic pancreatitis or pancreatic cancer)
- Control 2 (Chronic Pancreatitis)
- are undergoing EUS and/or ERCP for evaluation and/or treatment of suspected or proven chronic pancreatitis as part of their standard medical care, and,
- have no clinical or radiologic suspicion of pancreatic cancer
You may not qualify if…
- Patients will be excluded if they have any of the following:
- medical comorbidities or coagulopathy that contraindicate endoscopy,
- Karnosfky performance status of < 60,
- had partial or complete resection of their pancreas
- had a partial or complete gastrectomy with Billroth or Roux-en-Y anastomosis
- a stricture or obstruction in the upper GI tract that does not allow passage of the echoendoscope
- life expectancy less than 5 years due to coexisting advanced cancer or AIDS.
- inability to provide informed consent
- pregnant patient
- history of pancreatic cancer,
- suspicion of pancreatic neoplasia based on clinical history (weight loss, unexplained abdominal pain), physical examination (obstructive jaundice, cachexia), laboratory tests (cholestastic liver function tests, markedly elevated CA19-9), and/or imaging studies (pancreatic mass or cyst, dilated pancreatic and/or bile duct);
- there is no interest in undergoing treatment of pancreatic neoplasm(s) detected by screening.
- history of chronic kidney disease, serum creatinine > 2.0 mg/dl or estimated glomerulofiltration rate (eGFR) < 30 ml/min, ongoing acute renal failure, cirrhosis of the liver, chronic hepatitis (The estimated glomerulfiltration rate (eGFR) will be calculated based on age, race, and serum creatinine, using the on-line calculator at nephron.com).
- history of dementia
Where it is running
- Johns Hopkins Hospital — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.